Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Free Cash Flow Generation Index

Latest as of December 2025: 0.32x

Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Free Cash Flow Generation Index of 0.32x as of December 2025. Free cash flow of $13.27 Million represents 0% of operating cash flow ($41.05 Million). See Zhengye Biotechnology Holding Limited Or (ZYBT) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.32x
Free Cash Flow / Operating CF

Free Cash Flow

$13.27 Million
USD

Operating Cash Flow

$41.05 Million
USD

Capital Expenditures

$27.77 Million
USD

Zhengye Biotechnology Holding Limited Ordinary Shares Free Cash Flow Generation Index (2021–2025)

Historical FCF Generation Index trend for Zhengye Biotechnology Holding Limited Ordinary Shares across 5 annual periods. Explore ZYBT operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)

Year-by-year Free Cash Flow Generation Index for Zhengye Biotechnology Holding Limited Ordinary Shares. For the full company profile including market capitalisation, see how much is Zhengye Biotechnology Holding Limited Or worth.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 0.32x $13.27 Million $41.05 Million $27.77 Million ▲ +0.0%
2024 0.32x $13.27 Million $41.05 Million $27.77 Million ▼ -57.4%
2023 0.76x $36.58 Million $48.18 Million $11.60 Million ▲ +231.7%
2022 -0.58x $-9.99 Million $17.34 Million $27.33 Million ▼ -439.0%
2021 0.17x $5.41 Million $31.81 Million $26.40 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).